Dendrimers as Nanocarriers for the Delivery of Drugs Obtained from Natural Products

Natural products have proven their value as drugs that can be therapeutically beneficial in the treatment of various diseases. However, most natural products have low solubility and poor bioavailability, which pose significant challenges. To solve these issues, several drug nanocarriers have been developed. Among these methods, dendrimers have emerged as vectors for natural products due to their superior advantages, such as a controlled molecular structure, narrow polydispersity index, and the availability of multiple functional groups. This review summarizes current knowledge on the structures of dendrimer-based nanocarriers for natural compounds, with a particular focus on applications in alkaloids and polyphenols. Additionally, it highlights the challenges and perspectives for future development in clinical therapy.

[1]  Wen Zhang,et al.  Strategies and Lessons Learned from Total Synthesis of Taxol. , 2023, Chemical reviews.

[2]  A. Goel Current understanding and future prospects on Berberine for anticancer therapy , 2023, Chemical biology & drug design.

[3]  A. Banerjee,et al.  A Comprehensive Study on the Anti-cancer Effects of Quercetin and Its Epigenetic Modifications in Arresting Progression of Colon Cancer Cell Proliferation , 2023, Archivum Immunologiae et Therapiae Experimentalis.

[4]  Moein Askarpour,et al.  Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. , 2023, Cytokine.

[5]  M. Najafi,et al.  Immunoregulation by resveratrol; implications for normal tissue protection and tumour suppression , 2023, Clinical and experimental pharmacology & physiology.

[6]  Gang Fan,et al.  Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies , 2023, International journal of molecular sciences.

[7]  Wei Wang,et al.  Possible Mechanisms of Oxidative Stress-Induced Skin Cellular Senescence, Inflammation, and Cancer and the Therapeutic Potential of Plant Polyphenols , 2023, International journal of molecular sciences.

[8]  G. Sethi,et al.  Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements , 2023, Pharmaceutics.

[9]  D. Barreca,et al.  Targets Involved in the Anti-Cancer Activity of Quercetin in Breast, Colorectal and Liver Neoplasms , 2023, International journal of molecular sciences.

[10]  M. Guo,et al.  Modulating Inflammation-Mediated Diseases via Natural Phenolic Compounds Loaded in Nanocarrier Systems , 2023, Pharmaceutics.

[11]  Boyuan Zhang,et al.  The current scenario of naturally occurring indole alkaloids with anticancer potential. , 2023, Fitoterapia.

[12]  M. Portillo,et al.  Relationship between changes in microbiota induced by resveratrol and its anti-diabetic effect on type 2 diabetes , 2023, Frontiers in Nutrition.

[13]  A. Emwas,et al.  Alkaloids as potential antivirals. A comprehensive review , 2023, Natural Products and Bioprospecting.

[14]  H. K. Dewangan,et al.  Grafting, characterization and enhancement of therapeutic activity of berberine loaded PEGylated PAMAM dendrimer for cancerous cell , 2022, Journal of biomaterials science. Polymer edition.

[15]  Xuyang Gao,et al.  New insights into mechanisms of berberine in alleviating reproductive disorders of polycystic ovary syndrome: Anti-inflammatory properties. , 2022, European journal of pharmacology.

[16]  W. Liu,et al.  Pharmacological Activity of Quercetin: An Updated Review , 2022, Evidence-based complementary and alternative medicine : eCAM.

[17]  L. Grumetto,et al.  Recent Advances in Natural Polyphenol Research , 2022, Molecules.

[18]  D. Osinová,et al.  Natural Taxanes: From Plant Composition to Human Pharmacology and Toxicity , 2022, International journal of molecular sciences.

[19]  S. Fouladdel,et al.  Quercetin Effects on Cell Cycle Arrest and Apoptosis and Doxorubicin Activity in T47D Cancer Stem Cells , 2022, Asian Pacific journal of cancer prevention : APJCP.

[20]  Zhidan Liu,et al.  A review of plant antipathogenic constituents: Source, activity and mechanism. , 2022, Pesticide biochemistry and physiology.

[21]  Zhongyu Zhang,et al.  Progress in the Preclinical and Clinical Study of Resveratrol for Vascular Metabolic Disease , 2022, Molecules.

[22]  Xiaoyong Zhang,et al.  Facile synthesis of curcumin-containing poly(amidoamine) dendrimers as pH-responsive delivery system for osteoporosis treatment. , 2022, Colloids and surfaces. B, Biointerfaces.

[23]  T. Emran,et al.  A spotlight on alkaloid nanoformulations for the treatment of lung cancer , 2022, Frontiers in Oncology.

[24]  P. Dalerba,et al.  Therapeutic Nanocarriers Inhibit Chemotherapy‐Induced Breast Cancer Metastasis , 2022, Advanced science.

[25]  A. All,et al.  Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics. , 2022, Small.

[26]  E. Moghimipour,et al.  Ocular Delivery of Quercetin Using Microemulsion System: Design, Characterization, and Ex-vivo Transcorneal Permeation , 2022, Iranian journal of pharmaceutical research : IJPR.

[27]  H. Yang,et al.  Dendrimer-based drug delivery systems: history, challenges, and latest developments , 2022, Journal of Biological Engineering.

[28]  Yunjian Zhang,et al.  Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review , 2022, Molecules.

[29]  R. Dinarvand,et al.  Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds , 2022, Frontiers in Chemistry.

[30]  Asghar Narmani,et al.  Margetuximab conjugated-PEG-PAMAM G4 nano-complex: a smart nano-device for suppression of breast cancer , 2022, Biomedical Engineering Letters.

[31]  P. Bharatam,et al.  Drug-dendrimer complexes and conjugates: Detailed furtherance through theory and experiments. , 2022, Advances in colloid and interface science.

[32]  Yaseen Hussain,et al.  Antimicrobial Potential of Curcumin: Therapeutic Potential and Challenges to Clinical Applications , 2022, Antibiotics.

[33]  V. Garg,et al.  Gallic acid: a dietary polyphenol that exhibits anti-neoplastic activities by modulating multiple oncogenic targets. , 2021, Anti-cancer agents in medicinal chemistry.

[34]  Linjie Huang,et al.  Gallic Acid: A Potential Anti-Cancer Agent , 2021, Chinese Journal of Integrative Medicine.

[35]  M. Martínez-García,et al.  Click reaction in the synthesis of dendrimer drug-delivery systems. , 2021, Current Medicinal Chemistry.

[36]  D. Kohtz,et al.  Curcumin Loaded Dendrimers Specifically Reduce Viability of Glioblastoma Cell Lines , 2021, Molecules.

[37]  A. Mishra,et al.  Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of Silybin , 2021, Drug Research.

[38]  Xiangyang Shi,et al.  Clinical diagonal translation of nanoparticles: Case studies in dendrimer nanomedicine. , 2021, Journal of Controlled Release.

[39]  G. Orive,et al.  Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise. , 2021, European journal of medicinal chemistry.

[40]  I. Mourtzinos,et al.  Innovative Delivery Systems Loaded with Plant Bioactive Ingredients: Formulation Approaches and Applications , 2021, Plants.

[41]  M. Farzaei,et al.  Recent Advances in Improved Anticancer Efficacies of Camptothecin Nano-Formulations: A Systematic Review , 2021, Biomedicines.

[42]  L. Barros,et al.  Phenolic compounds: current industrial applications, limitations and future challenges. , 2020, Food & function.

[43]  M. Sadeghizadeh,et al.  Mitochondria-Targeted Polyamidoamine Dendrimer-Curcumin Construct for Hepatocellular Cancer Treatment. , 2020, Molecular pharmaceutics.

[44]  Gurinder Singh Resveratrol: nanocarrier-based delivery systems to enhance its therapeutic potential. , 2020, Nanomedicine.

[45]  Zhenzhong Wang,et al.  Berberine: a Promising Natural Isoquinoline Alkaloid for Development of Hypolipidemic Drug. , 2020, Current topics in medicinal chemistry.

[46]  L. Rus,et al.  Applications and Limitations of Dendrimers in Biomedicine , 2020, Molecules.

[47]  Ajay Kumar,et al.  Surface modified PAMAM dendrimers with gallic acid inhibit, cell proliferation, cell migration and inflammatory response to augment apoptotic cell death in human colon carcinoma cells , 2020, Journal of biomolecular structure & dynamics.

[48]  David John Adams,et al.  N-acetyl-D-glucosamine-conjugated PAMAM Dendrimers as Dual Receptor-Targeting Nanocarriers for Anticancer Drug Delivery. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[49]  M. Miao,et al.  Characterizations and bioavailability of dendrimer-like glucan nanoparticulate system containing resveratrol. , 2020, Journal of agricultural and food chemistry.

[50]  M. Tso,et al.  Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[51]  B. Ghosh,et al.  Cell-Penetrating Peptide and α-Tocopherol-Conjugated Poly(amidoamine) Dendrimers for Improved Delivery and Anticancer Activity of Loaded Paclitaxel. , 2020, ACS applied bio materials.

[52]  Zhuxian Zhou,et al.  Enzyme-Triggered Transcytosis of Dendrimer-Drug Conjugate for Deep Penetration into Pancreatic Tumors. , 2020, ACS nano.

[53]  B. Salehi,et al.  Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases , 2020, Journal of clinical medicine.

[54]  P. Kesharwani,et al.  Curcumin loaded poly (amidoamine) dendrimer-plamitic acid core-shell nanoparticles as anti-stress therapeutics , 2020, Drug development and industrial pharmacy.

[55]  Michael R Hamblin,et al.  Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells. , 2019, Colloids and surfaces. B, Biointerfaces.

[56]  F. Veiga,et al.  Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications , 2019, Materials.

[57]  V. Torchilin,et al.  Transferrin/α-tocopherol modified poly(amidoamine) dendrimers for improved tumor targeting and anticancer activity of paclitaxel. , 2019, Nanomedicine.

[58]  A. Ramazani,et al.  pH-sensitive magnetite nanoparticles modified with hyperbranched polymers and folic acid for targeted imaging and therapy. , 2019, Current drug delivery.

[59]  N. Ward,et al.  Anti-Angiogenic Activity of Curcumin in Cancer Therapy: A Narrative Review. , 2019, Current vascular pharmacology.

[60]  Hu Yang,et al.  Drug-Conjugated Dendrimer Hydrogel Enables Sustained Drug Release via a Self-Cleaving Mechanism. , 2019, Molecular pharmaceutics.

[61]  B. Ghosh,et al.  α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy. , 2019, Molecular pharmaceutics.

[62]  B. Ghosh,et al.  Biotin functionalized PEGylated poly(amidoamine) dendrimer conjugate for active targeting of paclitaxel in cancer , 2019, International journal of pharmaceutics.

[63]  Carola Díaz,et al.  Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin , 2018, Pharmaceutical development and technology.

[64]  B. Ghosh,et al.  Octa-arginine modified poly(amidoamine) dendrimers for improved delivery and cytotoxic effect of paclitaxel in cancer , 2018, Artificial cells, nanomedicine, and biotechnology.

[65]  H. Danafar,et al.  PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells , 2018, Drug development and industrial pharmacy.

[66]  Y. Yao,et al.  Octenylsuccinate hydroxypropyl phytoglycogen, a dendrimer-like biopolymer, solubilizes poorly water-soluble active pharmaceutical ingredients. , 2018, Carbohydrate polymers.

[67]  Marwa Masoud,et al.  Gallic acid–PAMAM and gallic acid–phospholipid conjugates, physicochemical characterization and in vivo evaluation , 2018, Pharmaceutical development and technology.

[68]  Xiao Zheng,et al.  Developments in drug delivery of bioactive alkaloids derived from traditional Chinese medicine , 2018, Drug delivery.

[69]  Yi Sun,et al.  Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM–camptothecin conjugate , 2017, Drug delivery.

[70]  Chen Gao,et al.  In vitro studies of phospholipid-modified PAMAM-siMDR1 complexes for the reversal of multidrug resistance in human breast cancer cells. , 2017, International journal of pharmaceutics.

[71]  M. P. Khinchi,et al.  Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics. , 2017, International journal of pharmaceutics.

[72]  V. Yellepeddi,et al.  Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer Cells. , 2017, Macromolecular bioscience.

[73]  Ziying Li,et al.  Role of generation on folic acid-modified poly(amidoamine) dendrimers for targeted delivery of baicalin to cancer cells. , 2017, Materials science & engineering. C, Materials for biological applications.

[74]  Sonam Choudhary,et al.  Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules , 2017, Front. Pharmacol..

[75]  Mohammad Ramezani,et al.  Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. , 2017, International journal of pharmaceutics.

[76]  Z. Gu,et al.  Enzyme-Sensitive and Amphiphilic PEGylated Dendrimer-Paclitaxel Prodrug-Based Nanoparticles for Enhanced Stability and Anticancer Efficacy. , 2017, ACS applied materials & interfaces.

[77]  O. Yesil‐Celiktas,et al.  Synthesis of silica-PAMAM dendrimer nanoparticles as promising carriers in Neuro blastoma cells. , 2017, Analytical biochemistry.

[78]  G. Velderrain‐Rodríguez,et al.  Gastrointestinal interactions, absorption, splanchnic metabolism and pharmacokinetics of orally ingested phenolic compounds. , 2017, Food & function.

[79]  S. Mutalik,et al.  Skin Delivery of EGCG and Silibinin: Potential of Peptide Dendrimers for Enhanced Skin Permeation and Deposition , 2017, AAPS PharmSciTech.

[80]  A. Chauhan,et al.  Development of a Topical Resveratrol Formulation for Commercial Applications Using Dendrimer Nanotechnology , 2017, Molecules.

[81]  Hongmei Jiang,et al.  Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes , 2016, Mediators of inflammation.

[82]  N. K. Jain,et al.  Ligand anchored poly(propyleneimine) dendrimers for brain targeting: Comparative in vitro and in vivo assessment. , 2016, Journal of colloid and interface science.

[83]  Siling Wang,et al.  Study on enhanced lymphatic exposure of polyamidoamin-alkali blue dendrimer for paclitaxel delivery and influence of the osmotic pressure on the lymphatic targeting , 2016, Drug delivery.

[84]  N. Gamage,et al.  Targeted Theranostic Approach for Glioma Using Dendrimer-Based Curcumin Nanoparticle , 2016, Journal of nanomedicine & nanotechnology.

[85]  Ž. Knez,et al.  Polyphenols: Extraction Methods, Antioxidative Action, Bioavailability and Anticarcinogenic Effects , 2016, Molecules.

[86]  Mauro F. A. Adamo,et al.  New Dendrimer-Based Nanoparticles Enhance Curcumin Solubility , 2016, Planta Medica.

[87]  Yulong Yin,et al.  Quercetin, Inflammation and Immunity , 2016, Nutrients.

[88]  V. Lather,et al.  Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid , 2016, Drug delivery.

[89]  V. Verma,et al.  Role of Curcumin in Common Musculoskeletal Disorders: a Review of Current Laboratory, Translational, and Clinical Data , 2015, Orthopaedic surgery.

[90]  R. Bei,et al.  In Vitro and in Vivo Antitumoral Effects of Combinations of Polyphenols, or Polyphenols and Anticancer Drugs: Perspectives on Cancer Treatment , 2015, International journal of molecular sciences.

[91]  A. Caminade,et al.  Dendrimers for drug delivery. , 2014, Journal of materials chemistry. B.

[92]  J. Ong,et al.  Design of a paclitaxel prodrug conjugate for active targeting of an enzyme upregulated in breast cancer cells. , 2014, Molecular pharmaceutics.

[93]  S. Pricl,et al.  Combination of dendrimer-nanovector-mediated small interfering RNA delivery to target Akt with the clinical anticancer drug paclitaxel for effective and potent anticancer activity in treating ovarian cancer. , 2014, Journal of medicinal chemistry.

[94]  Keerti Jain,et al.  Dendrimer as nanocarrier for drug delivery , 2014 .

[95]  V. Křen,et al.  Biotransformation of silybin and its congeners. , 2013, Current drug metabolism.

[96]  Huan He,et al.  Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin , 2013, Pharmaceutical development and technology.

[97]  Jiye Shi,et al.  Encapsulation of curcumin within poly(amidoamine) dendrimers for delivery to cancer cells , 2013, Journal of Materials Science: Materials in Medicine.

[98]  M. Inglés,et al.  [Resveratrol: distribution, properties and perspectives]. , 2013, Revista espanola de geriatria y gerontologia.

[99]  A. D'emanuele,et al.  Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. , 2013, International journal of pharmaceutics.

[100]  R. O'Regan,et al.  The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy , 2012, Chemotherapy research and practice.

[101]  N. K. Jain,et al.  Synthesis, characterization and brain targeting potential of paclitaxel loaded thiamine-PPI nanoconjugates , 2012, Journal of drug targeting.

[102]  D. Wallace Mitochondria and cancer , 2012, Nature Reviews Cancer.

[103]  M Ferrari,et al.  Nanovector delivery of siRNA for cancer therapy , 2012, Cancer Gene Therapy.

[104]  Yiyun Cheng,et al.  Inclusion complexes of isoflavones with two commercially available dendrimers: Solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities. , 2011, International journal of pharmaceutics.

[105]  Kaoxiang Sun,et al.  Effects of poly(amidoamine) dendrimers on ocular absorption of puerarin using microdialysis. , 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[106]  Kaoxiang Sun,et al.  Determination of puerarin in rabbit aqueous humor by liquid chromatography tandem mass spectrometry using microdialysis sampling after topical administration of puerarin PAMAM dendrimer complex. , 2011, Journal of pharmaceutical and biomedical analysis.

[107]  Xing Tang,et al.  Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats , 2011, AAPS PharmSciTech.

[108]  Anupama Sharma,et al.  Surface modified dendrimers: synthesis and characterization for cancer targeted drug delivery. , 2011, Bioorganic & medicinal chemistry.

[109]  Qin Chen,et al.  Polyamidoamine dendrimers as potential drug carriers for enhanced aqueous solubility and oral bioavailability of silybin , 2011, Drug development and industrial pharmacy.

[110]  N. K. Jain,et al.  Development and characterization of triazine based dendrimers for delivery of antitumor agent. , 2010, Journal of nanoscience and nanotechnology.

[111]  Kaoxiang Sun,et al.  Preparation and characterization of puerarin–dendrimer complexes as an ocular drug delivery system , 2010, Drug development and industrial pharmacy.

[112]  Na Liang,et al.  Effect of poly(amidoamine) dendrimers on corneal penetration of puerarin. , 2010, Biological & pharmaceutical bulletin.

[113]  A. Ray,et al.  PAMAM-Camptothecin Conjugate Inhibits Proliferation and Induces Nuclear Fragmentation in Colorectal Carcinoma Cells , 2010, Pharmaceutical Research.

[114]  C. Kang,et al.  Downregulation of miR-21 Enhances Chemotherapeutic Effect of Taxol in Breast Carcinoma Cells , 2010, Technology in cancer research & treatment.

[115]  F. Szoka,et al.  Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates. , 2009, Molecular pharmaceutics.

[116]  M. Clifford,et al.  Dietary phenolics: chemistry, bioavailability and effects on health. , 2009, Natural product reports.

[117]  Hye-Seon Choi,et al.  Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells. , 2008, Molecules and cells.

[118]  Lie-Chwen Lin,et al.  Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application. , 2007, Journal of pharmaceutical and biomedical analysis.

[119]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[120]  N. Vorsa,et al.  Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. , 2006, Bioconjugate chemistry.

[121]  Jianjun Cheng,et al.  Pharmacokinetics and biodistribution of the camptothecin–polymer conjugate IT-101 in rats and tumor-bearing mice , 2006, Cancer Chemotherapy and Pharmacology.

[122]  Daniel Normolle,et al.  Dose escalation of a curcuminoid formulation , 2006, BMC complementary and alternative medicine.

[123]  T. Walle,et al.  HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS , 2004, Drug Metabolism and Disposition.

[124]  Kinam Park,et al.  Hydrotropic dendrimers of generations 4 and 5: synthesis, characterization, and hydrotropic solubilization of paclitaxel. , 2004, Bioconjugate chemistry.

[125]  S. Jee,et al.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.

[126]  M. Majeed,et al.  Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. , 1998, Planta medica.

[127]  R. Kuttan,et al.  Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. , 1992, Indian journal of physiology and pharmacology.

[128]  Yixin Zhou,et al.  Efficacy and side effect of curcumin for the treatment of osteoarthritis: A meta-analysis of randomized controlled trials. , 2019, Pakistan journal of pharmaceutical sciences.

[129]  Youqing Shen,et al.  Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer. , 2017, Small.

[130]  D. Kroetz,et al.  Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review , 2017, Clinical Pharmacokinetics.

[131]  A. Akbarzadeh,et al.  PAMAM dendrimers augment inhibitory effects of curcumin on cancer cell proliferation: possible inhibition of telomerase. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[132]  Kaoxiang Sun,et al.  [Corneal penetration of PAMAM dendrimers-coated puerarin liposomes]. , 2010, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[133]  Gary Williamson,et al.  Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. , 2005, The American journal of clinical nutrition.